This is unpublished
Nora Disis
Society for Immunotherapy of Cancer (SITC) logo
August 21, 2026

Nora Disis elected fellow of the Academy of Immuno-Oncology

This recognition highlights scientists who have made groundbreaking contributions in cancer immunotherapy.
Scroll for more
arrow icon
Back to top
Categories
Awards Faculty

Dr. Mary (Nora) Disis, professor (Hematology and Oncology) and director of the Cancer Vaccine Institute, has been selected by the Society for Immunotherapy of Cancer (SITC) as a 2026 Fellow of the Academy of Immuno-Oncology.

This recognition highlights scientists who have made groundbreaking contributions in cancer immunotherapy and is one of SITC’s most prestigious honors.